NCT05585307 - Study of Novel Antiretrovirals in Participants With HIV-1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

February 17, 2024

Study Completion Date

March 18, 2024

Conditions

HIV-1-infection

Interventions

DRUG

Bavtavirine

Administered orally

DRUG

B/F/TAF

Administered orally

DRUG

Standard of Care (Substudy 01)

"Antiretroviral therapy, administered orally~Non-NNRTIs, examples: ABC/DTG/3TC; DTG plus (TAF or TDF) plus (FTC or 3TC)"

DRUG

GS-1720

Administered orally

DRUG

Standard of Care (Substudy 02)

"Antiretroviral therapy, administered orally~Example INSTIs: DTG/ABC/3TC or DTG/3TC"

DRUG

GS-6212

Administered orally

DRUG

Standard of Care (Substudy 03)

Antiretroviral therapy, administered orally

Trial Locations (42)

10103

Instituto Dominicano de Estudio Virologicos - IDEV,Substudy-02, Santo Domingo

10330

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),Substudy-02, Bangkok

The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),Substudy-03, Bangkok

20017

Washington Health Institute,Substudy-01, Washington D.C.

Washington Health Institute,Substudy-02, Washington D.C.

Washington Health Institute,Substudy-03, Washington D.C.

30033

Infectious Disease Specialists of Atlanta,Substudy-01, Decatur

32720

Midland Florida Clinical Research Center, LLC,Substudy-02, DeLand

Midland Florida Clinical Research, LLC,Substudy-03, DeLand

32803

Bliss Health,Substudy-02, Orlando

Bliss Health,Substudy-03, Orlando

Orlando Immunology Center,Substudy-01, Orlando

Orlando Immunology Center,Substudy-03, Orlando

33407

Triple O Research Institute, P.A.,Substudy-01, West Palm Beach

Triple O Research Institute, P.A.,Substudy-03, West Palm Beach

34982

Midway Immunology and Research Center,Substudy-01, Ft. Pierce

Midway Immunology and Research Center,Substudy-02, Ft. Pierce

Midway Immunology and Research Center,Substudy-03, Ft. Pierce

40002

Faculty of Medicine, Srinagarind Hospital, Khon Kaen University,Substudy-03, Khon Kaen

45267

University of Cincinnati College of Medicine,Substudy-02, Cincinnati

University of Cincinnati College of Medicine,Substudy-03, Cincinnati

46202

Indiana CTSI Clinical Research Center,Substudy-01, Indianapolis

75208

Prism Health North Texas,Substudy-02, Dallas

75215

Prism Health North Texas,Substudy-03, Dallas

75246

North Texas Infectious Diseases Consultant, P.A.,Substudy-02, Dallas

North Texas Infectious Diseases Consultants, P.A.,Substudy-03, Dallas

77004

Therapeutic Concepts, PA,Substudy-02, Houston

Therapeutic Concepts, PA,Substudy-03, Houston

77098

The Crofoot Research Center, Inc.,Substudy-01, Houston

78705

Central Texas Clinical Research,Substudy-01, Austin

Central Texas Clinical Research,Substudy-03, Austin

79902

AXCES Research,Substudy-02, El Paso

AXES Research Group LLC,Substudy-03, El Paso

90069

Mills Clinical Research,Substudy-02, Los Angeles

Mills Clinical Research,Substudy-03, Los Angeles

90813

Long Beach Education and Research Consultants,Substudy-03, Long Beach

94115

Quest Clinical Research,Substudy-01, San Francisco

Quest Clinical Research,Substudy-02, San Francisco

Quest Clinical Research,Substudy-03, San Francisco

99202

MultiCare Rockwood Main Clinic- Research,Substudy-03, Spokane

06510

Yale University; School of Medicine; AIDS Program (Administrative & Study Supplies),Substudy-03, New Haven

06520

Yale University,Substudy-02, New Haven